PUBLISHER: The Business Research Company | PRODUCT CODE: 1387718
PUBLISHER: The Business Research Company | PRODUCT CODE: 1387718
Implantable Drug Delivery Devices Global Market Report 2024
“Implantable Drug Delivery Devices Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on implantable drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for implantable drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The implantable drug delivery devices market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
- 1) By Product: Contraceptive Implants; Spinal Implants; Brachytherapy Seeds; Drug-Eluting Stents; Bio-absorbable Stents; Intraocular Stents; Infusion Pumps; Other Applications
- 2) By Technology: Diffusion; Osmotic; Magnetic; Other Technologies
- 3) By Application: Contraception; Ophthalmology; Cardiovascular; Diabetes; Oncology; Autoimmune Diseases; Other Applications
- Companies Mentioned: AbbVie Inc.; Bayer HealthCare; Medtronic Inc.; Nucletron; Boston Scientific Corporation
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Executive Summary
Implantable drug delivery devices are specialized drug delivery systems that are surgically implanted beneath the skin. These devices release drugs from a reservoir directly into the bloodstream, enabling targeted drug delivery and reducing the need for larger doses, which, in turn, minimizes potential side effects.
The primary product categories within the domain of implantable drug delivery devices include contraceptive implants, spinal implants, brachytherapy seeds, drug-eluting stents, bioabsorbable stents, intraocular stents, infusion pumps, and various other devices. Spinal implants, for instance, aid surgeons in treating deformities, providing spinal stability, and promoting fusion during surgical procedures. These devices employ a range of technologies, including diffusion, osmosis, magnetic mechanisms, and others. They find applications in a variety of medical fields, such as contraception, ophthalmology, cardiovascular treatments, diabetes management, oncology, the treatment of autoimmune diseases, and other medical areas.
The implantable drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides implantable drug delivery devices market statistics, including implantable drug delivery devices industry global market size, regional shares, competitors with an implantable drug delivery devices market share, detailed implantable drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable drug delivery devices industry. This implantable drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The implantable drug delivery devices market size has grown strongly in recent years. It will grow from $19.66 billion in 2023 to $21.21 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The expansion observed in the historical period can be attributed to several factors, including an aging population, a higher prevalence of chronic diseases, increased consumer awareness, a growing emphasis on preventive healthcare, and a rising demand for personalized medicine.
The implantable drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $28.91 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The anticipated growth in the forecast period can be attributed to various factors, including the adoption of customized drug delivery solutions, increased demand for minimally invasive surgeries, rising healthcare expenditure, the global expansion of healthcare services, developments in regenerative and genomic medicine. Notable trends expected in this period encompass technological innovations, advancements in biotechnology, the emergence of micro-implants, AI-powered dosage adjustment, synergies with telemedicine, the utilization of advanced biocompatible materials, and enhancements in drug delivery technology.
The increasing prevalence of target diseases such as diabetic retinopathy, cancer, cardiovascular conditions, and other chronic ailments is poised to be a driving force behind the growth of the implantable drug delivery devices market. Notably, in October 2022, the World Health Organization (WHO) reported a 3% rise in the burden of drug-resistant tuberculosis (DR-TB) between 2020 and 2021, with 450,000 new cases of rifampicin-resistant TB (RR-TB) in 2021. This marked the first increase in TB and drug-resistant TB cases in several years. The site-specific drug administration capabilities of implantable drug devices have played a crucial role in treating these target diseases, fueling the demand for such devices in the market.
The increasing incidence of chronic diseases is also expected to be a significant driver of growth in the implantable drug delivery devices market. Chronic diseases are characterized by their long-lasting nature, lasting for three months or more. Implantable drug delivery devices are increasingly being employed to facilitate controlled and long-term medication administration for chronic diseases, thereby improving patient adherence and treatment efficacy. For instance, the World Health Organization (WHO) reported in September 2022 that chronic diseases are responsible for 74% of global deaths, with 41 million fatalities each year. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the escalating prevalence of chronic diseases is a key driver behind the growth of the implantable drug delivery devices market.
The market is expected to face challenges due to the increasing number of product recalls and legal disputes associated with implantable drug delivery devices in recent years. For instance, in June 2022, Medtronic plc issued a recall of Cobalt XT, Cobalt, and Crome Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds). The recall was prompted by reports of devices generating a short circuit protection (SCP) alert, resulting in the delivery of reduced-energy electric shocks instead of the intended high-voltage therapy. This malfunction could lead to device failure and irregular heartbeats, potentially causing more serious health issues. Consequently, the growing number of product recalls and legal disputes associated with implantable drug delivery devices is likely to impede the market's growth.
Innovation efforts within the industry are focused on the development of 3D printing materials to support implantable drug delivery devices. These materials are used in additive manufacturing processes, such as 3D printing, to create customized and precise drug delivery systems. For instance, a study published in 2022 proposed the use of 3D-printed implants in combination with biodegradable rate-controlling membranes to produce devices capable of sustained delivery of hydrophobic drugs.
Major companies operating in the implantable drug delivery devices market are pursuing strategic partnerships to create an ultrasonic, non-invasive ocular drug delivery device. These partnerships involve companies collaborating and leveraging their respective strengths and resources for mutual benefits and success. For example, in May 2022, Opharmic Technology, a Hong Kong-based medtech company, partnered with CeramTec, a Germany-based chemical industry company, to develop innovative technology for non-invasively delivering drugs to the eyes. The aim is to replace intravitreal injections by using ultrasound-induced microstreaming to allow drug molecules to diffuse into the target eye tissue. This has the potential to revolutionize the treatment of various eye conditions.
In February 2022, Second Sight Medical Products, a California-based prosthetic device manufacturer, merged with Nano Precision Medical, a developer of NanoPortal drug implant technology. This merger paves the way for collaborative efforts in the development of drug delivery medical implants.
Major companies operating in the implantable drug delivery devices market include AbbVie Inc., Bayer HealthCare, Medtronic Inc., Nucletron, Boston Scientific Corporation, Abbott Laboratories, Bausch and Lomb Inc., Merck & Co. Inc., Genentech Inc., EyePoint Pharmaceuticals Inc., DSM Biomedical, Delpor Inc., Teleflex Incorporated, 3M Company, Biotronik Inc., Alcon Inc., Terumo Corporation, Endologix Inc., TransEnterix Inc., China Grand Pharmaceutical and Healthcare Holdings, Innocoll Biotherapeutics, Atossa Therapeutics Inc., Intersect ENT, Microchips Biotech, Theradaptive Inc., CollPlant, Intarcia Therapeutics, Glaukos Corporation
North America was the largest region in the implantable drug delivery devices market in 2023. Asia-Pacific was the second-largest region in the implantable drug delivery devices market report. The regions covered in the implantable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the implantable drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The implantable drug delivery devices market consists of sales of contraceptive implants, spinal implants, brachytherapy seeds, drug-eluting stents, bio-absorbable stents, intraocular stents, infusion pumps, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Table of Contents
1. Executive Summary
2. Implantable Drug Delivery Devices Market Characteristics
3. Implantable Drug Delivery Devices Market Trends And Strategies
4. Implantable Drug Delivery Devices Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Implantable Drug Delivery Devices Market Size and Growth
- 5.1. Global Implantable Drug Delivery Devices Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Implantable Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Implantable Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Implantable Drug Delivery Devices Market Segmentation
- 6.1. Global Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Contraceptive Implants
- Spinal Implants
- Brachytherapy Seeds
- Drug-Eluting Stents
- Bio-Absorbable Stents
- Intraocular Stents
- Infusion Pumps
- Other Applications
- 6.2. Global Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Diffusion
- Osmotic
- Magnetic
- Other Technologies
- 6.3. Global Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Contraception
- Ophthalmology
- Cardiovascular
- Diabetes
- Oncology
- Autoimmune Diseases
- Other Applications
7. Implantable Drug Delivery Devices Market Regional And Country Analysis
- 7.1. Global Implantable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Implantable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Implantable Drug Delivery Devices Market
- 8.1. Asia-Pacific Implantable Drug Delivery Devices Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Implantable Drug Delivery Devices Market
- 9.1. China Implantable Drug Delivery Devices Market Overview
- 9.2. China Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Implantable Drug Delivery Devices Market
- 10.1. India Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Implantable Drug Delivery Devices Market
- 11.1. Japan Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.2. Japan Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Implantable Drug Delivery Devices Market
- 12.1. Australia Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Implantable Drug Delivery Devices Market
- 13.1. Indonesia Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Implantable Drug Delivery Devices Market
- 14.1. South Korea Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.2. South Korea Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Implantable Drug Delivery Devices Market
- 15.1. Western Europe Implantable Drug Delivery Devices Market Overview
- 15.2. Western Europe Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Implantable Drug Delivery Devices Market
- 16.1. UK Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Implantable Drug Delivery Devices Market
- 17.1. Germany Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Implantable Drug Delivery Devices Market
- 18.5. France Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.6. France Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.7. France Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Implantable Drug Delivery Devices Market
- 19.9. Italy Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.10. Italy Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.11. Italy Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Implantable Drug Delivery Devices Market
- 20.13. Spain Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.14. Spain Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.15. Spain Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Implantable Drug Delivery Devices Market
- 21.1. Eastern Europe Implantable Drug Delivery Devices Market Overview
- 21.2. Eastern Europe Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Implantable Drug Delivery Devices Market
- 22.1. Russia Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Implantable Drug Delivery Devices Market
- 23.1. North America Implantable Drug Delivery Devices Market Overview
- 23.2. North America Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Implantable Drug Delivery Devices Market
- 24.1. USA Implantable Drug Delivery Devices Market Overview
- 24.2. USA Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Implantable Drug Delivery Devices Market
- 25.1. Canada Implantable Drug Delivery Devices Market Overview
- 25.2. Canada Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Implantable Drug Delivery Devices Market
- 26.1. South America Implantable Drug Delivery Devices Market Overview
- 26.2. South America Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Implantable Drug Delivery Devices Market
- 27.1. Brazil Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Implantable Drug Delivery Devices Market
- 28.1. Middle East Implantable Drug Delivery Devices Market Overview
- 28.2. Middle East Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Implantable Drug Delivery Devices Market
- 29.1. Africa Implantable Drug Delivery Devices Market Overview
- 29.2. Africa Implantable Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Implantable Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Implantable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Implantable Drug Delivery Devices Market Competitive Landscape And Company Profiles
- 30.1. Implantable Drug Delivery Devices Market Competitive Landscape
- 30.2. Implantable Drug Delivery Devices Market Company Profiles
- 30.2.1. AbbVie Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Bayer HealthCare
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Medtronic Inc.
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Nucletron
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Boston Scientific Corporation
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 30.2.1. AbbVie Inc.
31. Global Implantable Drug Delivery Devices Market Competitive Benchmarking
32. Global Implantable Drug Delivery Devices Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Implantable Drug Delivery Devices Market
34. Implantable Drug Delivery Devices Market Future Outlook and Potential Analysis
- 34.1 Implantable Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
- 34.2 Implantable Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
- 34.3 Implantable Drug Delivery Devices Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies
35. Appendix
- 35.1. Abbreviations
- 35.2. Currencies
- 35.3. Historic And Forecast Inflation Rates
- 35.4. Research Inquiries
- 35.5. The Business Research Company
- 35.6. Copyright And Disclaimer
